Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, engages in the research, development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products in the People's Republic of China. The company develops products in the areas of vascular interventional therapy for the treatment of atrial fibrillation, hypertension, and other cardiovascular diseases; and natural orifice transluminal endoscopic surgery for the treatment of urinary, respiratory, and digestive diseases. It also provides vascular intervention products comprising the AF cryoablation system, cryo-RDN system, and pulmonary hypertension cryoablation system; respiratory intervention products consisting of the COPD cryospray system, asthma cryoablation system, malignant stenosis cryoablation system, benign stenosis cryoablation system, peri-pulmonary nodule cryoablation system, cough cryospray system, tuberculosis cryospray system, and cryoadhesion system; and cancer intervention products, including the bladder cryoablation system, gastric cryoablation system, and esophageal cryospray system. In addition, the company offers atrial fibrillation pulsed field ablation; anti-gastroesophageal reflux system; pulmonary nodule localization needle; endoscopic clip for anastomosis; laparoscopic single port multi-channel access platform; wound retractors for small incision and minimally invasive surgery; ureteral dilation balloon catheters for ureteral stricture; laparoscopic biopsy bags for biopsy; laparoscopic surgical instruments for laparoscopy applications; transseptal guiding introducer for cardiac interventional surgery; endoscopic additional working channel catheter for interventional endoscopy procedures; and minimally invasive surgical consumables. Cryofocus Medtech (Shanghai) Co., Ltd. was incorporated in 2013 and is based in Shanghai, the People's Republic of China.
